Literature DB >> 9393735

Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities.

G Sozzi1, S Tornielli, E Tagliabue, L Sard, F Pezzella, U Pastorino, F Minoletti, S Pilotti, C Ratcliffe, M L Veronese, P Goldstraw, K Huebner, C M Croce, M A Pierotti.   

Abstract

Genomic alterations and abnormal expression of the FHIT gene at 3p14.2 have been observed in cell lines and primary tumors of the lung. To correlate FHIT locus DNA and RNA lesions with effects on Fhit protein expression, we have analyzed 11 lung cancer cell lines, 15 small cell lung carcinomas, and 38 pairs of non-small cell primary tumors and bronchial mucosa specimens by molecular genetic and immunocytochemical methods. Using specific antibodies against the Fhit protein, we observed concordance between RNA abnormalities and lack of Fhit protein expression in lung tumors and cell lines. In addition, absence of Fhit protein in some precancerous dysplastic lesions suggested that FHIT inactivation may occur at an early phase of lung carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393735

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Lack of association of fragile histidine triad (FHIT) polymorphisms with lung cancer in the Korean population.

Authors:  Hae-Yun Jung; Jae Sook Sung; Young Mi Whang; Hyoung Doo Shin; Byung Lae Park; Jun Suk Kim; Sang Won Shin; Hee Yun Seo; Hwa Jung Sung; In Keun Choi; Sang Cheul Oh; Jae Hong Seo; Yeul Hong Kim
Journal:  J Hum Genet       Date:  2007-07-04       Impact factor: 3.172

Review 2.  Pulmonary preinvasive neoplasia.

Authors:  K M Kerr
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

3.  Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit.

Authors:  H C Pace; P N Garrison; A K Robinson; L D Barnes; A Draganescu; A Rösler; G M Blackburn; Z Siprashvili; C M Croce; K Huebner; C Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

4.  High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesis.

Authors:  Roberto Jose Diaz; Mustafa Guduk; Rocco Romagnuolo; Christian A Smith; Paul Northcott; David Shih; Fitim Berisha; Adrienne Flanagan; David G Munoz; Michael D Cusimano; M Necmettin Pamir; James T Rutka
Journal:  Neoplasia       Date:  2012-09       Impact factor: 5.715

5.  Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer.

Authors:  Alba Rocco; Laslo Schandl; Jie Chen; Hongbing Wang; Zsolt Tulassay; Deirdre McNamara; Peter Malfertheiner; Matthias P A Ebert
Journal:  J Cancer Res Clin Oncol       Date:  2003-03-04       Impact factor: 4.553

6.  Immunohistochemical characterization of FHIT expression in normal human tissues.

Authors:  Omar Kujan; Abdulwahab Abuderman; Ahmad Zahi Al-Shawaf
Journal:  Interv Med Appl Sci       Date:  2016-03

7.  The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control.

Authors:  L Sard; P Accornero; S Tornielli; D Delia; G Bunone; M Campiglio; M P Colombo; M Gramegna; C M Croce; M A Pierotti; G Sozzi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

8.  A knockdown with smoke model reveals FHIT as a repressor of Heme oxygenase 1.

Authors:  Jennifer A Boylston; Charles Brenner
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Fhit is a physiological target of the protein kinase Src.

Authors:  Yuri Pekarsky; Preston N Garrison; Alexey Palamarchuk; Nicola Zanesi; Rami I Aqeilan; Kay Huebner; Larry D Barnes; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-08       Impact factor: 11.205

10.  Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans.

Authors:  Y Pekarsky; M Campiglio; Z Siprashvili; T Druck; Y Sedkov; S Tillib; A Draganescu; P Wermuth; J H Rothman; K Huebner; A M Buchberg; A Mazo; C Brenner; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.